Brady Corporation declares regular dividend to shareholders MILWAUKEE, May 21, 2024 (GLOBE NEWSWIRE) -- On May 20, 2024, Brady Corporation’s (NYSE: BRC) Board of Directors declared a dividend to shareholders of the company’s Class A Common Stock of $0.235 per share, payable on July 31, 2024, to shareholders of record at the close of business on July 10, 2024. Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance a...
Alta Equipment Group Announces Pricing of Private Offering of $500 Million of Senior Secured Second Lien Notes due 2029 LIVONIA, Mich., May 21, 2024 (GLOBE NEWSWIRE) -- Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the “Company”), announced today that it has priced $500 million in aggregate principal amount of its 9.000% senior secured second lien notes due 2029 (the “notes”) at an issue price of 97.094% of face amount in a private offering (the “offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The offering ...
Moody's Ratings (Moody's) has assigned an A1 underlying rating and Aa1 enhanced rating to Cloquet Independent School District 94, MN's General Obligation Facilities Maintenance Bonds, Series 2024A, which have a proposed par amount of $5.4 million. Moody's maintains the district's A1 issuer rating an...
According to our tracker, Evolution’s strong trading has continued more than halfway into Q2, with H1 player volumes up c40% YOY and 6% MOM so far in May. Given the strong fundamentals and support from our data, we believe that the weak share price gives a good buying opportunity. In June Evolution plans to launch ‘Lightning Storm’ (likely its largest launch ever), and finally we note that our player data correlates almost exactly with the company’s own ‘Game Rounds Index’. We reiterate our BUY ...
Moody's Ratings (Moody's) upgraded the ratings of Indivior Finance S.ar.l., an indirect wholly-owned subsidiary of Indivior PLC and RBP Global Holdings Ltd (collectively "Indivior"), including the Corporate Family Rating (CFR) to B1 from B2, the Probability of Default Rating (PDR) to B1-PD from B2-P...
Moody's Ratings (Moody's) has today affirmed Votorantim Cimentos S.A. (VC)'s Baa3 issuer rating. At the same time, Moody's affirmed the Baa3 ratings of the existing backed senior unsecured notes issued by St. Marys Cement Inc. and Votorantim Cimentos International S.A., and guaranteed by VC. The out...
Moody's Ratings (Moody's) has today affirmed Votorantim S.A. (VSA)'s Baa3 issuer rating. The outlook for the rating remains stable. RATINGS RATIONALE Votorantim's Baa3 rating is supported by the company's size and market position as the holding company of one of the largest conglomerates in Braz...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Equinix, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 21 May 2024 in which Moody's reassessed the appropriateness of the ratings in the context of ...
Moody's Ratings (Moody's) has upgraded the ratings of two bonds issued by Shellpoint Co-Originator Trust 2017-1. The collateral backing this deal consists of prime jumbo mortgage loans. Please click on this link /viewresearchdoc.aspx?docid=PBS_ARFTL490568 for the List of Affect...
Nature Medicine hebt signifikante Verbesserung der Hand- und Armfunktion nach einer Rückenmarksverletzung durch die ONWARD® ARC-EX® Therapie hervor ARC Therapy™ hat sich in einer globalen Zulassungsstudie* als sicher und wirksam erwiesen 90 % der Teilnehmer verbesserten entweder die Kraft oder die Funktion der oberen Gliedmaßen* Verbesserung bei Teilnehmern bis zu 34 Jahre nach der Verletzung nachgewiesen* 87 % der Teilnehmer berichteten auch über eine Verbesserung der allgemeinen Lebensqualität* EINDHOVEN, Niederlande, May 21, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: O...
Nature Medicine se réjouit de partager l’amélioration significative de la fonction de la main et du bras après une lésion de la moelle épinière grâce à la thérapie ONWARD® ARC-EX® Therapy La thérapie ARC Therapy™ s’est révélée sûre et efficace dans le cadre d’une étude pivot mondiale* Quatre-vingt-dix pour cent des participants ont amélioré la force ou la fonction de leurs membres supérieurs* Amélioration démontrée chez les participants jusqu’à 34 ans après la blessure* Quatre-vingt-sept pour cent des participants ont également fait état d’une amélioration de leur qualité de vie globale*...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of Padagis LLC and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 May 2024 in which Moody's reassessed the appropriateness of the ratings in the context of th...
Solaris Resources Announces $35 Million Common Share Bought Deal Offering NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that it has entered into an agreement with National Bank Financial Markets, RBC Capital Markets, and BMO Capital Markets as bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, ...
Solaris Resources Announces $35 Million Common Share Bought Deal Offering VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that it has entered into an agreement with certain underwriters, (the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 7,150,000 common shares of the Company (the “Common Shares”) at a price of $4.90 per Common Share (the “Offering Price”), for aggregate gross proceeds of approximately $35,035,000 million (t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.